Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2019Journal of Medical EconomicsOpen Access

Incentives and disincentives to drug innovation: evidence from recent literature

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRoger Lee MendozaCalifornia State University System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Roger Lee Mendoza (2019) studied this question.

synapsesocial.com/papers/6aaa48a3d0a3c768807e6065https://doi.org/10.1080/13696998.2019.1613240
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Information Asymmetries and Risk Management in Healthcare Markets: The U.S. Affordable Care Act in Retrospect2017 · 4 citations